<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although recent data shows that <z:chebi fb="0" ids="30621">arsenic trioxide</z:chebi> (<z:chebi fb="0" ids="30621">As2O3</z:chebi>) is capable of inducing cell <z:hpo ids='HP_0011420'>death</z:hpo> via cell cycle arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> both in <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> (APL) and in non-APL cells, the mechanisms of <z:chebi fb="0" ids="30621">As2O3</z:chebi>-mediated cell <z:hpo ids='HP_0011420'>death</z:hpo> are not fully understood </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the in vitro effects of <z:chebi fb="0" ids="30621">As2O3</z:chebi> on cell growth inhibition and cell <z:hpo ids='HP_0011420'>death</z:hpo> in human T-lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) cell lines </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="30621">As2O3</z:chebi> significantly inhibited the proliferation of Molt-4 and Mutz-1 cells in dose- and time-dependent manner </plain></SENT>
<SENT sid="3" pm="."><plain>Autophagic cell <z:hpo ids='HP_0011420'>death</z:hpo> (programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> type II) and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> type I) were activated together in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines after exposed to <z:chebi fb="0" ids="30621">As2O3</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Numerous large cytoplasmic inclusions and vacuoles were observed in <z:chebi fb="0" ids="30621">As2O3</z:chebi>-treated cells using electron microscope </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, <z:chebi fb="0" ids="38635">3-methyladenine</z:chebi> (an autophagy inhibitor) significantly reduced autophagic cell <z:hpo ids='HP_0011420'>death</z:hpo> and sequentially induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells treated with 4 microM <z:chebi fb="0" ids="30621">As2O3</z:chebi> showed a considerable up-regulation of Beclin-1 (a Bcl-2-interacting protein) expression, which was independent of transcription of <z:chebi fb="2" ids="33699">mRNA</z:chebi> and required protein synthesis </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, Molt-4 cells treated with <z:chebi fb="0" ids="30621">As2O3</z:chebi> exhibited the down-regulation of Bax protein expression, suggesting that Bax may be involved in accumulating of Beclin-1 and triggering autophagic cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:chebi fb="0" ids="30621">As2O3</z:chebi>-treated <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells </plain></SENT>
<SENT sid="8" pm="."><plain>These results may lead to a better understanding of the mechanism of action of <z:chebi fb="0" ids="30621">As2O3</z:chebi>, and provide a suggestion that <z:chebi fb="0" ids="30621">As2O3</z:chebi> may be of therapeutic value for the treatment of patients with human T-lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
</text></document>